Mythic Therapeutics: Funding, Investors & Team (Oct 2026)
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics. The company is pioneering a powerful protein engineering-focused approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics. Their technology dramatically increases therapeutic potency without compromising safety, thereby unlocking the full potential of targeted therapies against a broad array of tumor targets.
Mythic Therapeutics has raised $103M across 1 funding round on record, the most recent a Series B of $103M announced in Dec 2021.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Mythic Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2021.
Mythic Therapeutics Funding Rounds
Mythic Therapeutics Founders and Leadership Team
Contact details for the Mythic Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Mythic Therapeutics Funding Compared to Other Biotechnology Startups
Mythic Therapeutics' latest round of $103M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Mythic Therapeutics in Biotechnology and Waltham
Companies Similar to Mythic Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Mythic Therapeutics Funding FAQs
What does Mythic Therapeutics do?
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics. The company is pioneering a powerful protein engineering-focused approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics. Their technology dramatically increases therapeutic potency without compromising safety, thereby unlocking the full potential of targeted therapies against a broad array of tumor targets.
How much funding has Mythic Therapeutics raised?
Mythic Therapeutics has raised $103M across 1 round on record. The most recent is a Series B of $103M announced in Dec 2021.
When did Mythic Therapeutics last raise funding?
Mythic Therapeutics' most recent funding round on record is a Series B of $103M, announced in Dec 2021.
Who is the CEO of Mythic Therapeutics?
Alex Nichols is listed as CEO at Mythic Therapeutics.
Where is Mythic Therapeutics headquartered?
Mythic Therapeutics is based in Waltham, Massachusetts, United States.
How many employees does Mythic Therapeutics have?
Mythic Therapeutics is in the 11-50 employee band.
How does Mythic Therapeutics' funding compare to other Biotechnology startups?
Mythic Therapeutics' latest round of $103M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Mythic Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mythic Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.